Ruben A. Mesa, MD, FACP, executive director of the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, has played a key role as both an investigator and aiding the drug development for the past eight years to get RoPEG INFa2b (besremi) approved in PV.

Cancer survivorship is an emerging area of research, yet the survivorship experience differs significantly between racial-ethnic groups. Latinos with cancer, for example, face a challenging survivorship journey marked by advanced disease, poor quality of life, and stressful socioeconomic inequities. The Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, is working […]

Of the patients surveyed, 56% reported receiving at least one dose of a COVID-19 vaccination, which is lower than the community vaccination rate of 76%.

The “Living Beyond Cancer A-Z: A Mays Cancer Center, home to UT Health Antonio MD Anderson Symposium,” featuring a full day of learning, empowerment a

Researchers at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), reporting this week in the journal Proceedings of the National Academy of Sciences, identified a mechanism through which two antiviral genes, when mutated, promote a childhood cancer called pediatric myelodysplastic syndrome (MDS). Scientists at Oklahoma State University and Cornell University collaborated […]

Heidi Ko, MD, joins our breast oncology team as an assistant professor focusing on breast medical oncology. Dr. Ko received her medical degree from Rowan University School of Osteopathic Medicine in Stratford, New Jersey. She completed her residency in internal medicine at McGovern Medical School at The University of Texas Health Science Center at Houston. […]